A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
Launched by PFIZER · Oct 6, 2023
Trial Information
Current as of July 07, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants aged 18 years or older at screening.
- • Diagnosis of RSV infection collected within 5 days prior to randomization.
- • New onset or worsening (if present chronically) of at least one of the following signs and/or symptoms consistent with a viral acute respiratory infection (ARI), within 5 days prior to randomization: nasal congestion, nasal discharge, sore throat, cough, sputum production, shortness of breath, or wheezing.
- • Has at least 1 of the following characteristics or underlying medical conditions: a) 65 years of age or older b) Chronic lung disease, c) Heart failure, d) Immunosuppressive disease/condition or immune-weakening medications
- Exclusion Criteria:
- • Any medical or psychiatric condition that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study or interfere with the evaluation of response to the study intervention.
- • Diagnosis of viral respiratory infections other than RSV including influenza and SARS-CoV-2
- • Current need for hospitalization or anticipated need for hospitalization for any reason to provide inpatient/acute care within 24 hours after randomization
- • Any clinically significant ECG abnormality in the pre-dose ECG that, per investigator judgement, may affect participant safety
- • Has hypersensitivity to or other contraindication to any of the components of the study interventions, as determined by the investigator.
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clearwater, Florida, United States
Geelong, Victoria, Australia
Okayama, , Japan
Taipei, , Taiwan
Taipei, , Taiwan
Uniontown, Pennsylvania, United States
Beijing, Beijing, China
Guangzhou, Guangdong, China
Hamilton, Ontario, Canada
Butte, Montana, United States
Krugersdorp, Gauteng, South Africa
Centerville, Ohio, United States
Okayama, , Japan
Kiyose, Tokyo, Japan
Wuhan, Hubei, China
Changsha, Hunan, China
Benoni, Gauteng, South Africa
Little Rock, Arkansas, United States
Sapporo, Hokkaido, Japan
Shantou, Guangdong, China
Asahikawa, Hokkaido, Japan
Kanazawa, Ishikawa, Japan
Camp Hill, Pennsylvania, United States
Kaohsiung, , Taiwan
Surat, Gujarat, India
Pretoria, Gauteng, South Africa
Johannesburg, Gauteng, South Africa
Wuhan, Hubei, China
San Antonio, Texas, United States
Bloemfontein, Free State, South Africa
Los Angeles, California, United States
Pretoria West, Gauteng, South Africa
Chattanooga, Tennessee, United States
Hangzhou, , China
Kawachinagano, Osaka, Japan
Shanghai, Shanghai, China
Kamakura, Kanagawa, Japan
Troy, Michigan, United States
Yanagawa, Fukuoka, Japan
Fukuyama, Hiroshima, Japan
Joyo, Kyoto, Japan
Charlotte, North Carolina, United States
Canoga Park, California, United States
Guangzhou, , China
Cullman, Alabama, United States
Houston, Texas, United States
Bronx, New York, United States
Chuo Ku, Tokyo, Japan
Huntington Beach, California, United States
Coffs Harbour, New South Wales, Australia
Mesquite, Texas, United States
Pomona, California, United States
Miyazaki, , Japan
Tsuchiura, Ibaraki, Japan
Medford, Oregon, United States
Hialeah, Florida, United States
Oxnard, California, United States
Okayama, , Japan
Pittsburgh, Pennsylvania, United States
Las Vegas, Nevada, United States
Nampa, Idaho, United States
Clinton, Utah, United States
Victoria, British Columbia, Canada
Miami Lakes, Florida, United States
Houston, Texas, United States
Nanyang, Henan, China
Colorado Springs, Colorado, United States
Garden Grove, California, United States
Mount Dora, Florida, United States
Chula Vista, California, United States
Pembroke Pines, Florida, United States
Grosse Pointe Woods, Michigan, United States
El Paso, Texas, United States
Moncks Corner, South Carolina, United States
Wilmington, North Carolina, United States
Fuyang, Anhui, China
Huizhou, Guangdong, China
Nanchang, Jiangxi, China
Las Vegas, Nevada, United States
Lewisville, Texas, United States
Ajmer, Rajasthan, India
Las Vegas, Nevada, United States
San Diego, California, United States
Athens, Alabama, United States
Worcester, Massachusetts, United States
Farmington Hills, Michigan, United States
Salisbury, North Carolina, United States
Dallas, Texas, United States
Coral Gables, Florida, United States
Cutler Bay, Florida, United States
Miami, Florida, United States
Jaipur, Rajasthan, India
Narita, Chiba, Japan
Columbia, South Carolina, United States
Gaffney, South Carolina, United States
Lake City, Florida, United States
Hinesville, Georgia, United States
Miami, Florida, United States
Houston, Texas, United States
Bangalore, Karnataka, India
Dallas, Texas, United States
Pittsburgh, Pennsylvania, United States
Pretoria, Gauteng, South Africa
Fort Lauderdale, Florida, United States
Oak Lawn, Illinois, United States
Rocky Mount, North Carolina, United States
Dallas, Texas, United States
Winchester, Ontario, Canada
Savannah, Georgia, United States
Stephenville, Texas, United States
North Hollywood, California, United States
Kyoto Shi, Kyoto, Japan
Largo, Florida, United States
Doral, Florida, United States
Saint Petersburg, Florida, United States
Rockville, Maryland, United States
Taringa, Queensland, Australia
Doral, Florida, United States
Chatsworth, Kwazulu Natal, South Africa
Vestal, New York, United States
Inglewood, California, United States
Gulfport, Mississippi, United States
New Delhi, Delhi, India
Hialeah, Florida, United States
Coconut Creek, Florida, United States
Grand Island, Nebraska, United States
Charlotte, North Carolina, United States
Lincoln, Nebraska, United States
Andrews, Texas, United States
Rockville, Maryland, United States
Edmond, Oklahoma, United States
Norfolk, Nebraska, United States
Frisco, Texas, United States
Chizhou, Anhui, China
Long Beach, California, United States
Irvine, California, United States
Victorville, California, United States
Westminster, California, United States
Westminster, California, United States
Ocean Township, New Jersey, United States
Yukon, Oklahoma, United States
Carrollton, Texas, United States
Plano, Texas, United States
Pretoria, Gauteng, South Africa
Dehradun, Uttarakhand, India
Mobile, Alabama, United States
Brea, California, United States
Oakland, California, United States
Pomona, California, United States
Edgewater, Florida, United States
Miami, Florida, United States
Brooklyn, New York, United States
Austin, Texas, United States
Kawasaki Shi, Kanagawa, Japan
Pasadena, California, United States
Mount Dora, Florida, United States
Ciudad De Buenos Aires, Buenos Aires, Argentina
Pasadena, California, United States
Homestead, Florida, United States
Immokalee, Florida, United States
Ormond Beach, Florida, United States
Charlotte, North Carolina, United States
Edmond, Oklahoma, United States
Austin, Texas, United States
Conroe, Texas, United States
Houston, Texas, United States
Paris, Texas, United States
Sugar Land, Texas, United States
Tomball, Texas, United States
Shanghai, Shanghai, China
Kitakyushu, Fukuoka, Japan
Yaese, Okinawa, Japan
Athens, Alabama, United States
Saint Petersburg, Florida, United States
Johannesburg, Gauteng, South Africa
Columbia, Maryland, United States
Shanghai, , China
Shimajiri, Okinawa, Japan
Hamamatsu, Shizuoka, Japan
Melbourne, Victoria, Australia
Polokwane, Limpopo, South Africa
Bakersfield, California, United States
Las Vegas, Nevada, United States
Brooklyn, New York, United States
Frisco, Texas, United States
Houston, Texas, United States
Missouri City, Texas, United States
Shiogama, Miyagi, Japan
S. Gate, California, United States
Silver Spring, Maryland, United States
Mankato, Minnesota, United States
Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
St Leonards, New South Wales, Australia
Geelong, Victoria, Australia
Guangzhou, Guangdong, China
Nanning, Guangxi Zhuang Autonomous Regin, China
Nanning, Guangxi, China
Bengaluru, Karnataka, India
Middelburg, Mpumalanga, South Africa
Mesquite, Texas, United States
Polokwane, Limpopo, South Africa
Brooklyn, New York, United States
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported